Where did Matthew Henn go to school?

Matthew Henn studied at University of California, Berkeley (Ph.D., Microbiology; Ecosystem Sciences); University of New Hampshire (B.S., Ecology & Evolutionary Biology); Harvard University.

Matthew Henn

President and Chief Scientific Officer at Seres Therapeutics

Greater Boston

Find your path to Matthew

1,334 people in our graph share verified history with Matthew — schools, employers, funds. One of them is your warm intro.

Yaryna NychunlockedMatthew: together at Harvard University (2016–2017)

×4Matthew: together at Broad Institute of MIT and Harvard

×4Matthew: together at Harvard University

×3Matthew: together at University of California, Berkeley

President and Chief Scientific Officer at Seres Therapeutics

Intro paths

→

In turn, Matthew can intro founders to Seres Therapeutics's investors below.

Seres Therapeutics's investors · 4

Fidelity InvestmentsBoston Flagship PioneeringCambridge · $500K – $10M checks · since 2014 RA CapitalBoston Sofinnova VenturesMenlo Park · $100K – $15M checks

Experience

Seres TherapeuticsPresident & Chief Scientific Officercurrent2026 — present
Seres TherapeuticsExecutive VP, Chief Scientific Officer2019 — 2026Cambridge, MA
Seres TherapeuticsExecutive VP, Microbiome Research & Development2018Cambridge, MA, USA
Seres Therapeutics (formally Seres Health)Senior VP, Head of Drug Discovery & Bioinformatics2014 — 2017Cambridge, MA 02142
Seres HealthHead of Drug Discovery2012 — 2014
Life Sciences CaresBoard Of Advisorscurrent2021 — present
Growcentia, IncScientific Advisory Board2015 — 2020
The Forsyth InstituteScientific Advisory Board2017 — 2019
Broad InstituteDirector Viral Genomics2010 — 2012
Broad Institute of MIT and HarvardAssistant Director Genomic Sequencing Center for Infectious Diseases2009 — 2012
Broad Institute of MIT and HarvardResearch Scientist II2006 — 2009
Broad Institute of MIT and HarvardResearch Scientist2005 — 2006
Duke UniversityNSF Fellow in Microbiology2003 — 2005
University of California, BerkeleyPostdoctoral Fellow - Microbial Ecology2003

Skills & more

GenomicsMicrobiologyInfectious DiseasesSequencingData AnalysisBioinformaticsComputational BiologyBiotechnologyMolecular BiologyScientific WritingLife SciencesFundraising

+12 more

microbiomePCRLifesciencesDNAGeneticsCell CultureIntellectual PropertyScientific PresentationStrategic PartnershipsStrategic PlanningStrategic ThinkingGrant Writing

From Matthew's professional profile.

Frequently asked questions

Who is Matthew Henn?: President and Chief Scientific Officer at Seres Therapeutics
Where does Matthew Henn work?: Matthew Henn is President and Chief Scientific Officer at Seres Therapeutics.
Where did Matthew Henn go to school?: Matthew Henn studied at University of California, Berkeley (Ph.D., Microbiology; Ecosystem Sciences); University of New Hampshire (B.S., Ecology & Evolutionary Biology); Harvard University.

Same school

Also attended University of California, Berkeley2,000

Byron DeeterPartner at Bessemer Venture Partners Steve WozniakCo-founder of Apple Tony XuCo-founder & CEO of DoorDash Aravind SrinivasCo-founder & CEO of Perplexity AI Ali GhodsiCo-founder & CEO of Databricks Ryan PetersenFounder & CEO of Flexport

+ 1,994 more

Also attended University of New Hampshire93

Jessica DowdInvestor at OpenView Venture Partners Rosemary SullivanOperations Manager at RET Ventures Andrew BrochuController at Castle Island Ventures Bryce BlairAdvisory Board at Navitas Capital Chris StoneInvestor at EPIC VENTURES Dillon HealyHead of Business Development & Capital Formation, North America at Sora Ventures

+ 87 more

Also attended Harvard University2,000

Ron ConwayFounder of SV Angel Alfred LinPartner at Sequoia Capital Chris DixonFounder & Managing Partner of a16z crypto at Andreessen Horowitz Sarah TavelVenture Partner at Benchmark Danny RimerPartner at Index Ventures Laela SturdyManaging Partner at CapitalG

+ 1,994 more

Shared employers

Also worked at Seres Therapeutics9

Noubar AfeyanInvestor at Flagship Pioneering Geoffrey von MaltzahnGeneral Partner at Flagship Pioneering ROGER POMERANTZDirector at VerImmune Wa'el HashadExecutive Officer, Director at Longeveron Kevin HorganHead of Research & Development at Melius Microbiomics David EgeChief Technical Officer at ADC Therapeutics SA

+ 3 more

Also worked at The Forsyth Institute3

Michael GreeleyCo-Founder and General Partner at Flare Capital Partners Elyse CherryCEO, BlueHub Capital at Reinventure Capital Kim CaponeChief Science Officer at Vaginal Biome Science

Also worked at Broad Institute90

Anika GuptaInvestor at GV (Google Ventures)Anthony PhilippakisInvestor at GV (Google Ventures)Issi RozenInvestor at GV (Google Ventures)Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Sid ShenaiVenture partner at Madrona and co-founder and CEO of Proof Diagnostics Susan LiuInvestment Team at 8VC

+ 84 more

Also worked at Duke University187

Fred EhrsamCo-founder and Senior Advisor at Paradigm; founder of Nudge Pae WuGeneral Partner at SOSV Akshita IyerCorporate Insights Lead at Tech Square Ventures Michael BrannanSr. Associate at Volition Capital Paige MorschauserHead of Operations at Red Cell Incubation Evan HenleyAssociate, Investments at Capital One Ventures

+ 181 more